Loading...

Buy Full Version
"Central Nervous System (CNS) Therapeutics Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Central Nervous System (CNS) Therapeutics Market by Disease Type (Infectious Diseases, Neurodegenerative Diseases, Autoimmune & Inflammatory Diseases, Genetic Disorders, Cancers, Trauma, and Psychiatric Disorders) and Application (Hospital, Clinic, Homecare, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

LI_195508
Pages: NA
Dec 2019 | 175 Views
 
Author(s) : NA
Tables: NA
Charts: NA
 

The central nervous system (CNS) is a vital part of the nervous system that consists the brain and the spinal cord. It integrates the received information, thereafter coordinating and controlling the activities of all parts of the body. However, CNS disorders such as neurodegenerative diseases, autoimmune & inflammatory diseases, genetic disorders, cancers, and others affect the structure and function of the brain or spinal cord. Thus, CNS therapeutics are used to treat these disorders. 

The growth of the CNS therapeutics market is primarily driven by advancements in diagnostics, therapeutics, and drug discovery techniques. Moreover, increase in demand for effective CNS therapeutic options encourages major pharmaceutical companies to invest in R&D, thus creating future growth opportunities. Furthermore, rise in awareness regarding psychiatric disorders, surge in prevalence of mental illness & lifestyle-associated CNS disorders, and increase in geriatric population boost the growth of the global market. The rate of serious psychological distress among adolescents and young adults has been on a rise since past few years, which further fuels the demand for CNS therapeutics across the globe. However, stringent & protracted drug approval procedures and soaring prices of advanced treatments are projected to restrain the growth of the CNS therapeutics market. On the contrary, lucrative opportunities in emerging economies due to various factors such as rise in awareness regarding CNS disorders and increase in healthcare expenditure by government & non-government organizations are expected to provide immense opportunities for the manufacturers in the industry. 

The World Health Organization and the American Association of Neurological Surgeons conduct various seminars to increase awareness about psychological disorders and their treatments. In addition, these organizations have helped to create groups in which patients can interact with each other as well as with the professionals and can have a holistic approach toward healing, which drives the market growth. Furthermore, advancements in technologies to develop superior drug delivery system and rise in R&D activities for introduction of novel drugs are anticipated to propel the market for CNS therapeutics. Moreover, upcoming pipeline therapeutics for CNS disorders by Healthcare giants such as Biogen, Inc. and Pfizer, Inc. is projected to accelerate the growth of the market. In addition, various other key players in the global CNS therapeutics market are heavily investing to bring superior therapeutics in the market, which provides remunerative opportunities for market expansion.

The global central nervous system therapeutics market is segmented into disease type, applications, and region. Based on disease type, the market is fragmented into infectious diseases, neurodegenerative diseases, autoimmune & inflammatory diseases, genetic disorders, cancers, trauma, and psychiatric disorders. The applications covered in the study include hospital, clinic, homecare, and others. Region wise, the market is thoroughly analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

This report provides a comprehensive analysis and profiles of major players such as Pfizer, Inc., Biogen, Inc., Johnson & Johnson Services, Inc., Eli Lilly and Company, Inc., Merck & Co., Inc., AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd., Shire Plc, and Allergan Plc. The other players in the value chain include Cipla Limited, GlaxoSmithKline plc, Lupin Limited, Otsuka Pharmaceutical Co., Ltd., Lundbeck, and others.

KEY BENEFITS FOR STAKEHOLDERS

  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the market is provided.
  • Region-wise and country-wise market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026 in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the CNS therapeutics market are profiled in this report, and their strategies are analyzed thoroughly, which help to understand the competitive outlook of global market.

KEY MARKET SEGMENTS:

By Disease Type

  • Infectious Diseases
  • Neurodegenerative Diseases 
  • Autoimmune and Inflammatory Diseases
  • Genetic Disorders 
  • Cancers 
  • Trauma
  • Psychiatric Disorders
  • Anxiety Disorders
  • Substance Abuse Disorders
  • Mood Disorders
  • Others

By Application

  • Hospital 
  • Clinic 
  • Homecare 
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

   

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

REQUEST TOC/SAMPLE

Request Customization

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Central Nervous System (CNS) Therapeutics Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,370  $4,833
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 
image image image image image image image image image image image image image image image image image image image
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
REQUEST TOC/SAMPLE